Concepedia

James M. Balkovec

JM

50

Publications

4.1K

Citations

32

H-Index

1983

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

James M. Balkovec is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1983–2020

50

Publications

50

On the use of the O-methylmandelate ester for establishment of absolute configuration of secondary alcohols

Barry M. Trost, John L. Belletire, Stephen A. Godleski et al. · The Journal of Organic Chemistry · 1986 · 574 citations

, , +16

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng et al. · The Journal of Experimental Medicine · 2005 · 362 citations · Full text

In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

K Bartizal, Christopher Gill, George K. Abruzzo et al. · Antimicrobial Agents and Chemotherapy · 1997 · 312 citations · Full text

, , +12

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

George K. Abruzzo, Amy Flattery, Christopher Gill et al. · Antimicrobial Agents and Chemotherapy · 1997 · 244 citations · Full text

The First Stereoselective Total Synthesis of Quinine

Gilbert Stork, Deqiang Niu, Azumi Fujimoto et al. · Journal of the American Chemical Society · 2001 · 203 citations

Rows per page

1–5 of 50